MedPath

Novazidime

Brand Name: Novazidime

Generic Name: Ceftazidime (as pentahydrate)

Active
Registration Number

DRP-11601

Dosage Form

Powder for Injection (I.M./I.V.)

Issuance Date

March 31, 2022

Expiry Date

March 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g
PackagingUSP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Yellow Flip-off seal (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftazidime (as pentahydrate)Active
Monograph: ceftazidime (as pentahydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform